Abstract
Fibroblast Activation Protein (FAP)-specific Positron Emission Tomography (PET) has shown promising results in various cancers. This pilot study compares FAP-specific PET to MRI for treatment planning in 13 Glioblastoma patients. The resulting incongruent volumes could provide additional information for radiotherapy or biopsy planning.
Author supplied keywords
Cite
CITATION STYLE
Windisch, P., Röhrich, M., Regnery, S., Tonndorf-Martini, E., Held, T., Lang, K., … Adeberg, S. (2020). Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma. Radiotherapy and Oncology, 150, 159–163. https://doi.org/10.1016/j.radonc.2020.06.040
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.